32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy

Carcinogenesis

Volumn 18, Issue 5, 1997, Pages 1063-1067

  Bieler, Christian A ^a   Stiborova, Marie ^b   Wiessler, Manfred ^a   Cosyns, Jean Pierre ^c   Van Ypersele De Strihou, Charles ^c   Schmeiser, Heinz H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTOLOCHIC ACID; CARCINOGEN; DNA; PHOSPHORUS 32; ARISTOLOCHIC ACID I; HERBACEOUS AGENT; PHENANTHRENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; CHINESE HERB; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; URETER; URINARY TRACT CANCER; ADULT; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; TIME; WISTAR RAT;

ADULT; ANIMALS; ARISTOLOCHIC ACIDS; DNA ADDUCTS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PHENANTHRENES; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0031284662     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.5.1063     Document Type: Article

References (38)

1. Vanherweghem, J.L., Depierreux, M., Tielemans, C., et al. (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet, 341, 387-391.
2. Van Ypersele de Strihou, C. and Vanherweghem, J.L. (1994) The tragic paradigm of Chinese herbs nephropathy. Nephrol. Dial. Transplant., 10, 157-160.
3. Cosyns, J-P., Jadoul, M., Squifflet, J-P., De Plaen, J-F., Ferluga, D. and van Ypersele de Strihou, C. (1994) Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int., 45, 1680-1688.
4. Depierreux, M., Van Damme, B., Vanden Houte, K. and Vanherweghem, J.L. (1994) Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis., 24, 172-180.
5. Vanhaelen, M., Vanhaelen Fastre, R., But, P. and Vanherweghem, J.L. (1994) Identification of aristolochic acid in Chinese herbs [letter]. Lancet, 343, 174.
6. Kupchan, S.M. and Doskotch, R.W. (1962) Tumor inhibitors. I. Aristolochic acid, the active principle of Aristolochia indica. J. Med. Pharm. Chem., 5, 657-659.
7. Möse, J.R. (1974) Weitere Studien über Aristolochiasäure. Arzneimittelforschung, 24, 151-153.
8. Kluthe, R., Vogt, A. and Batsford, S. (1982) Doppelblindstudie zur Beeinflussung der Phagocytosefähigkeit von Granulocyten durch Aristolochiasäure. Arzneimittelforschung, 32, 443-445.
9. Hedwall, P.R. (1961) Einfluß der Aristolochiasäure auf die Nierenfunktion der Ratte. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmacol, 241, 550-551
10. Thiele, K.G., Muehrcke, R.C. and Berning, H. (1967) Nierenerkrankungen durch Medikamente. Dtsch. Med. Wochensch., 92, 1632-1635.
11. Jackson, L., Kofman, S., Weiss, A. and Brodovsky, H. (1964) Aristolochic acid (NSC-50413): Phase I clinical study. Cancer Chemother. Rep., 42, 35-37.
12. Mengs, U., Lang, W. and Poch, J.A. (1982) The carcinogenic action of aristolochic acid in rats. Arch. Toxicol., 51, 107-119.
13. Mengs, U. (1988) Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol., 61, 504-505.
14. Robisch, G., Schimmer, O. and Goggelmann, W. (1982) Aristolochic acid is a direct mutagen in Salmonella typhimurium. Mutat. Res., 105, 201-204.
15. Schmeiser, H.H., Pool, B.L. and Wiessler, M. (1984) Mutagenicity of the two main components of commercially available carcinogenic aristolochic acid in Salmonella typhimurium. Cancer Lett., 23, 97-101.
16. Pfau, W., Schmeiser, H.H. and Wiessler, M. (1990) Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis, 11, 313-319.
17. 6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen. Chem. Res. Toxicol., 4, 581-586.
18. Schmeiser, H.H., Bieler, C.A., Wießler, M., van Ypersele de Strihou, C. and Cosyns, J.P. (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Research, 56, 2025-2028.
19. 32P-post-labelling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
20. 32P-postlabelling analysis using different chromatographic procedures. Carcinogenesis, 15, 1187-1192.
21. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis, 9, 1687-1693.
22. Broschard, T.H., Wiessler, M., von der Lieth, C.W. and Schmeiser, H.H. (1994) Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid. Carcinogenesis, 15, 2331-2340.
23. Everson, R.B., Randerath, E., Santella, R.M., Cefalo, R.C., Avitts, T.A. and Randerath, K. (1986) Detection of smoking-related covalent DNA adducts in human placenta. Science, 231, 54-57.
24. 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC. Sci. Publ., 124, 167-171.
25. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis, 11, 1627-1633.
26. 32P-post-labelling analysis of DNA adducts persisting for up to 42 weeks in the skin, epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis, 6, 1117-1126.
27. Alexandrov, K., Rojas, M., Bourgeois, Y. and Chouroulinkov, I. (1983) The persistence of benzo[a]pyrene diol-epoxide deoxyguanosine adduct in mouse skin and its disappearance in rat skin. Carcinogenesis, 4, 1655-1657.
28. Bailey, G.S., Williams, D.E., Wilcox, J.S., Loveland, P.M., Coulombe, R.A. and Hendricks, J.D. (1988) Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish. Carcinogenesis, 9, 1919-1926.
29. 32P-adduct assay: short- and long-term persistence of 2-acetylaminofluorene-DNA adducts and other applications of the assay. Cell Biol. Toxicol., 4, 467-474.
30. Gupta, R.C. and Dighe, N.R. (1984) Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene. Carcinogenesis, 5, 343-349.
31. Turesky, R.J., Markovic, J. and Aeschlimann, J.M. (1996) Formation and removal of C-8 and N2-guanine adducts of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in the liver, kidney, and colorectum of the rat. Chem. Res. Toxicol., 9, 397-402.
32. Ashurst, S.W., Cohen, G.M., Nesnow, S., DiGiovanni, J. and Slaga, T.J. (1983) Formation of benzo[a]pyrene/DNA adducts and their relationship to tumor initiation in mouse epidermis. Cancer Res., 43, 1024-1029.
33. 3H into deoxyribonucleic acid folowing administration of 7,12-dimethylbenz[a]anthracene. Proc. Natl. Acad. Sci. USA, 50, 454-459.
34. Hellman, B., D'argy, R. and Ullberg, S. (1984) The in vivo uptake of tritiated thymidine as a potential short-term test of toxic effects of polycyclic aromatic hydrocarbons in different organs. Toxicology, 29, 183-194.
35. 1: evidence for an inducible repair response. Cancer Res., 47, 1993-2001.
36. Schmeiser, H.H., Janssen, J.W., Lyons, J., Scherf, H.R., Pfau, W., Buchmann, A., Bartram, C.R. and Wiessler, M. (1990) Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res., 50, 5464-5469.
37. Cosyns, J.P., Jadoul, M., Squifflet, J.P., Van Cangh, P.J. and van Ypersele de Strihou, C. (1994) Urothelial malignancy in nephropathy due to Chinese herbs [letter]. Lancet, 344, 188.
38. Vanherweghem, J.L., Tielemans, C., Simon, J. and Depierreux, M. (1995) Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol. Dial. Transplant., 10, 270-273.